Back to results
US 2014/0154274 A1Published application
Methods and compositions for use in intralymphatic cellular therapies
AssigneesTigenix N.V., TiGenix, S.A.U.
InventorsEleuterio Lombardo, Wilfried Dalemans
Life of this patent
Estimating the term…
Abstract
The present invention provides medical uses and methods for the intralymphatic administration of cellular therapies. Further aspects of the invention provide compositions, kits and uses for the intralymphatic administration of cellular therapies.
Claims23
A method of treating or repairing damaged tissue;
- and/or treating, modulating, ameliorating and/or prophylaxis of one or more symptoms associated with inflammatory and/or immune disorders;
- said method comprising administering to the lymphatic system of said subject a prophylactically or therapeutically effective dosage regimen of a composition comprising stem cells, regulatory T-cells and/or fibroblast cells, wherein the dosage regimen comprises the administration of one dose, or multiple doses separated by at least 12 hours, wherein the or each dose comprises between 100,000 and 100 million cells.
(canceled)
(canceled)
(canceled)
-28. (canceled)
Dependencies are inferred from the claim text.